Aridis Pharmaceuticals Inc (ARDS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ARDS Annual Balance Sheets →
The balance sheet data below highlights changes in Aridis Pharmaceuticals Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent0.04
Cash & Short-term Investments0.00
Accounts receivable0.42
Other Receivables0.10
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.56
Total Current Assets4.11
Equipment/Property/Plant Net0.51
Intangible Assets0.01
Other Assets, Noncurrent1.90
Capitalized Contract Cost Net Current0.00
Restricted Cash Current0.00
Capitalized Contract Cost Net Noncurrent0.00
Total Assets6.53
Liabilities
Accounts Payable, Current AC5.41
Accrued Liabilities, Current AC7.69
Notes Payable, Current NO0.00
Other Liabilities, Current4.38
Total Current Liabilities17.48
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.85
ContractWithCustomerLiabilityNoncurrent0.00
Notes Payables Fair Value Current3.41
Contract With Customer Liability Current0.38
Total Liabilities18.34
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock170.83
Retained Earnings / Accumulated Deficit-190.42
Other Equity7.79
Common Stockholder's Equity-11.80
Total Stockholder's Equity-11.80
Liabilities & Stockholder's Equity6.53
4 historic quarters locked

Sign in to unlock the full Aridis Pharmaceuticals Inc balance sheet history.

About Aridis Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-23-039521

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.